TrialCancer research communications2025

First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.

Benedito A Carneiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.